- Work/Life Balance
- Culture & Values
- Career Opportunities
- Comp & Benefits
- Senior Management
I have been working at Spectrum Pharmaceuticals full-timeRecommendsPositive OutlookApproves of CEORecommendsPositive OutlookApproves of CEO
The company -- all of the staff from the CEO all the way through the organization -- are committed to do what's right for patients. And to doing what's right in general (eg, high ethical position).
The company is fiscally conservative while still understanding that you have to spend money (wisely) to make money. The pay isn't what you might get at big pharma but you get all the benefits of working for a small company (no bureaucracy, quick & fact-based decision-making, etc.) with the security of a company that has a healthy revenue stream.
Management truly care about the staff.
The pipeline is excellent.
The people are exceptional and the staff is highly diverse - unlike I've ever seen and I think that makes it a stronger and better place to work. Transparency is important and staff retention is a priority.
Free breakfast / bring your dog to work on Friday is a fun thing.
It's a virtual company so sometimes it feels hard to "own" the work. Telecommuting is not an option - reflective the CEO's philosophy that you need to be present to be effective -- and that might be a negative for some people (but not for me).
Advice to Management
Continue to reward and value the hard-working staff who uphold the values and ideals of the company.
Getting an Interview
Getting an Interview
Helpful (4)Accepted OfferPositive ExperienceAverage Interview
I applied online. The process took 3 weeks – interviewed at Spectrum Pharmaceuticals in May 2014.
Initial phone call, followed by five person interview schedule, with department manager, department employee, HR, section manager, different department employee with crossover interaction. Third interview with CEO regardless of job interviewing for.
- What are the key documents required for TMF's? Answer Question
Let us know if we're missing any workplace or industry recognition –
Spectrum Pharmaceuticals sees a rainbow of opportunities in its drug development pipeline. The drug firm, which focuses on anti-cancer therapies, markets injectable Fusilev for use with osteosarcoma patients; the drug reduces the toxic effects of a certain type of chemotherapy. Spectrum also sells Zevalin, a treatment for non-Hodgkin's lymphoma. In addition, the company has other oncology and urology therapeutic drug candidates in research and development stages, partially through licensing agreements or collaborative partnerships with other drugmakers.